Ground Swell Capital »

Abcellera Biologics shares owned by Ground Swell Capital

Quarter-by-quarter ownership of Abcellera Biologics (ABCL) shares owned by Ground Swell Capital from 13F filings

Historical chart of Ground Swell Capital investment in Abcellera Biologics

Tip: Access up to 7 years of quarterly data

All positions including Abcellera Biologics held by Ground Swell Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Abcellera Biologics by Ground Swell Capital

Quarter filed Position value Share count Share price at filing
2026-03-31 $55k 16k 3.49

More positions owned by Ground Swell Capital

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Vaneck Etf Trust Pharmaceutcl Etf (PPH)
NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Ishares Semicdtr (SOXX)
Duolingo Cl A Com (DUOL)
State Str Spdr Dow Jones Ind Ut Ser 1 (DIA)
Ishares Tr 20 Yr Tr Bd Etf (TLT)
Evergy (EVRG)
Charter Communications Cl A (CHTR)
State Str Spdr S&p Midcap 40 Utser1 S&pdcrp (MDY)
Meta Platforms Cl A (META)
Intuitive Surgical Com New (ISRG)
Sandisk Corp (SNDK)

View all positions for Ground Swell Capital

Top funds holding Abcellera Biologics

Baker Bros. Advisors
Capital World Investors
Ubs Global Asset Management Americas
Two Sigma Investments
Leucadia National Corporation
Two Sigma Advisers
Goldman Sachs Group
UBS Group
Arrowpoint Asset Management
BlackRock
Driehaus Capital Management
Renaissance Technologies
Susquehanna International
Citadel Advisors
Tudor Investment Corporation

View all funds holding Abcellera Biologics